ZA201306933B - Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fst titration escalating dosing regimen - Google Patents
Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fst titration escalating dosing regimenInfo
- Publication number
- ZA201306933B ZA201306933B ZA2013/06933A ZA201306933A ZA201306933B ZA 201306933 B ZA201306933 B ZA 201306933B ZA 2013/06933 A ZA2013/06933 A ZA 2013/06933A ZA 201306933 A ZA201306933 A ZA 201306933A ZA 201306933 B ZA201306933 B ZA 201306933B
- Authority
- ZA
- South Africa
- Prior art keywords
- fst
- interferon
- symptoms associated
- dosing regimen
- intramuscular administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161452807P | 2011-03-15 | 2011-03-15 | |
| US201161476930P | 2011-04-19 | 2011-04-19 | |
| PCT/US2012/029201 WO2012125809A1 (en) | 2011-03-15 | 2012-03-15 | Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201306933B true ZA201306933B (en) | 2016-07-27 |
Family
ID=46045072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2013/06933A ZA201306933B (en) | 2011-03-15 | 2013-09-12 | Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fst titration escalating dosing regimen |
Country Status (25)
| Country | Link |
|---|---|
| US (6) | US9198955B2 (enExample) |
| EP (1) | EP2686002B1 (enExample) |
| JP (2) | JP6279905B2 (enExample) |
| KR (1) | KR102050339B1 (enExample) |
| CN (1) | CN103702680A (enExample) |
| AU (1) | AU2012229104B2 (enExample) |
| BR (1) | BR112013023609A8 (enExample) |
| CA (1) | CA2846786C (enExample) |
| CY (1) | CY1120176T1 (enExample) |
| DK (1) | DK2686002T3 (enExample) |
| EA (1) | EA028448B1 (enExample) |
| ES (1) | ES2666850T3 (enExample) |
| HR (1) | HRP20180621T1 (enExample) |
| HU (1) | HUE036931T2 (enExample) |
| IL (1) | IL228425A (enExample) |
| LT (1) | LT2686002T (enExample) |
| MX (1) | MX359947B (enExample) |
| PL (1) | PL2686002T3 (enExample) |
| PT (1) | PT2686002T (enExample) |
| RS (1) | RS57175B1 (enExample) |
| SG (1) | SG193446A1 (enExample) |
| SI (1) | SI2686002T1 (enExample) |
| SM (1) | SMT201800221T1 (enExample) |
| WO (1) | WO2012125809A1 (enExample) |
| ZA (1) | ZA201306933B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012125809A1 (en) * | 2011-03-15 | 2012-09-20 | Biogen Idec Inc. | Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen |
| HK1226092A1 (zh) * | 2014-01-09 | 2017-09-22 | Kyushu University, National University Corporation | 制备小胶质细胞的方法 |
| WO2018056584A1 (ko) | 2016-09-21 | 2018-03-29 | 삼성전자 주식회사 | 피부 상태 측정 방법 및 이를 위한 전자 장치 |
| CN116391233A (zh) * | 2020-09-30 | 2023-07-04 | 皇家飞利浦有限公司 | 用于执行剂量滴定的方法和系统 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4456748A (en) | 1981-02-23 | 1984-06-26 | Genentech, Inc. | Hybrid human leukocyte interferons |
| DE3273787D1 (en) | 1981-02-04 | 1986-11-20 | Japan Found Cancer | Human interferon-beta gene |
| US4695543A (en) | 1982-03-23 | 1987-09-22 | Bristol-Myers Company | Alpha Interferon GX-1 |
| CA1302320C (en) | 1984-06-11 | 1992-06-02 | Hideo Niwa | Expression of human cromosomal interferon-_ in animal cells |
| US5231176A (en) | 1984-08-27 | 1993-07-27 | Genentech, Inc. | Distinct family DNA encoding of human leukocyte interferons |
| FI90990C (fi) | 1984-12-18 | 1994-04-25 | Boehringer Ingelheim Int | Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi |
| EP0205404B1 (en) | 1985-06-11 | 1992-07-15 | Ciba-Geigy Ag | Hybrid interferons |
| US5641656A (en) | 1993-10-22 | 1997-06-24 | University Of Connecticut | Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them |
| TR199901968T2 (xx) * | 1996-12-24 | 1999-12-21 | Biogen, Inc. | Sabit s�v� interferon form�lleri. |
| JP2001104482A (ja) * | 1999-10-07 | 2001-04-17 | Terumo Corp | ２室型プレフィルドシリンジ |
| ES2712469T3 (es) * | 2003-01-30 | 2019-05-13 | Becton Dickinson Co | Soporte con escudo de seguridad para un dispositivo de administración de fármaco |
| BRPI0510526A (pt) * | 2004-06-01 | 2007-10-30 | Ares Trading Sa | formulações lìquidas estabilizadas de interferon |
| US20060089593A1 (en) * | 2004-10-26 | 2006-04-27 | Sergio Landau | Needle-free injection device for individual users |
| EP1923085A1 (en) * | 2006-11-17 | 2008-05-21 | Sanofi-Aventis Deutschland GmbH | Dosing and drive mechanism for drug delivery device |
| JP2010513309A (ja) * | 2006-12-18 | 2010-04-30 | アルタス ファーマシューティカルズ インコーポレイテッド | ヒト成長ホルモン製剤 |
| US9044378B2 (en) * | 2007-05-31 | 2015-06-02 | Safety Syringes, Inc. | Anti-needle stick safety device or system for use with drugs requiring reconstitution |
| JP5549048B2 (ja) * | 2007-08-16 | 2014-07-16 | 味の素株式会社 | 薬剤バイアルとプレフィルドシリンジの接続構造 |
| WO2010148337A1 (en) * | 2009-06-18 | 2010-12-23 | Wyeth Llc | Lyophilized formulations for small modular immunopharmaceuticals |
| WO2012125809A1 (en) * | 2011-03-15 | 2012-09-20 | Biogen Idec Inc. | Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen |
-
2012
- 2012-03-15 WO PCT/US2012/029201 patent/WO2012125809A1/en not_active Ceased
- 2012-03-15 PL PL12719487T patent/PL2686002T3/pl unknown
- 2012-03-15 ES ES12719487.6T patent/ES2666850T3/es active Active
- 2012-03-15 JP JP2013558168A patent/JP6279905B2/ja active Active
- 2012-03-15 EA EA201301024A patent/EA028448B1/ru unknown
- 2012-03-15 US US13/421,197 patent/US9198955B2/en active Active
- 2012-03-15 AU AU2012229104A patent/AU2012229104B2/en active Active
- 2012-03-15 EP EP12719487.6A patent/EP2686002B1/en active Active
- 2012-03-15 PT PT127194876T patent/PT2686002T/pt unknown
- 2012-03-15 SI SI201231281T patent/SI2686002T1/en unknown
- 2012-03-15 HU HUE12719487A patent/HUE036931T2/hu unknown
- 2012-03-15 RS RS20180455A patent/RS57175B1/sr unknown
- 2012-03-15 BR BR112013023609A patent/BR112013023609A8/pt not_active Application Discontinuation
- 2012-03-15 HR HRP20180621TT patent/HRP20180621T1/hr unknown
- 2012-03-15 SM SM20180221T patent/SMT201800221T1/it unknown
- 2012-03-15 CA CA2846786A patent/CA2846786C/en active Active
- 2012-03-15 SG SG2013069018A patent/SG193446A1/en unknown
- 2012-03-15 LT LTEP12719487.6T patent/LT2686002T/lt unknown
- 2012-03-15 CN CN201280019863.2A patent/CN103702680A/zh active Pending
- 2012-03-15 KR KR1020137027053A patent/KR102050339B1/ko active Active
- 2012-03-15 DK DK12719487.6T patent/DK2686002T3/en active
- 2012-03-15 MX MX2013010507A patent/MX359947B/es active IP Right Grant
-
2013
- 2013-09-12 ZA ZA2013/06933A patent/ZA201306933B/en unknown
- 2013-09-12 IL IL228425A patent/IL228425A/en active IP Right Grant
-
2015
- 2015-11-09 US US14/936,228 patent/US20160101157A1/en not_active Abandoned
-
2017
- 2017-09-05 US US15/695,587 patent/US10500254B2/en active Active
- 2017-09-05 JP JP2017170640A patent/JP6522069B2/ja active Active
-
2018
- 2018-04-23 CY CY20181100424T patent/CY1120176T1/el unknown
-
2019
- 2019-10-22 US US16/660,038 patent/US20200046804A1/en not_active Abandoned
-
2022
- 2022-05-27 US US17/827,282 patent/US20220280610A1/en not_active Abandoned
-
2025
- 2025-05-05 US US19/198,871 patent/US20250276042A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE071510T2 (hu) | Az anti-alfa4béta7 antitest adagolási rendje | |
| PL2753700T3 (pl) | Sposób fermentacji | |
| EP2686759A4 (en) | IMPROVED TOUCH SURFACE | |
| GB2513690B (en) | Starting a process | |
| AP2013007105A0 (en) | Process for producing instant noodles | |
| PL2731607T3 (pl) | Sposób koordynacji czasu kolonoskopii, w którym podaje się kompozycję pikosiarczanową | |
| PL2789456T3 (pl) | Maszyna formująca opony o potrójnym bębnie i sposób przemieszczania w niej materiału | |
| EP2691517A4 (en) | FERMENTATION OF PENTOSES BY A RECOMBINANT MICROORGANISM | |
| GB2512214B (en) | Multi-touch interface schemes | |
| SG11201402773XA (en) | Gas injector apparatus for plasma applicator | |
| SG11201402865XA (en) | Method for detecting protein-protein interaction | |
| EP2771986A4 (en) | METHOD FOR PAGING-BASED DELEGATION DISPLAY FOR A M2M GROUP | |
| GB201119879D0 (en) | Green computing heterogeneous computer system | |
| GB2497856B (en) | Baby carriage | |
| PL2714888T3 (pl) | Rekombinowane drożdże | |
| AP2014007438A0 (en) | Fuel production apparatus | |
| IL213864A0 (en) | Method for removing a lytic enzyme from a heterogeneous mixture | |
| ZA201306933B (en) | Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fst titration escalating dosing regimen | |
| EP2788881A4 (en) | SERIES INTERFACE CHARGING TECHNIQUES | |
| EP2768760A4 (en) | PALETTENGABEL | |
| EP2720547A4 (en) | PROCESS FOR BENDAMUSTINE HYDROCHLORIDE | |
| PL2586945T3 (pl) | Wózek | |
| PL2794877T3 (pl) | Modyfikacja genu pnp w celu usprawnienia wykorzystania ksylozy przez zymomonas | |
| PL2788516T3 (pl) | Rozpoczynanie wytapiania | |
| PL2788515T3 (pl) | Rozpoczynanie wytapiania |